Resources

The leading source for ASAM society and addiction medicine news.

ASAM Hires Chief of Quality and Science

by ASAM Staff | Sep 05, 2018

The American Society of Addiction Medicine (ASAM) announced the hire of Maureen Boyle, PhD, as Chief Quality and Science Officer effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

She brings over ten years of experience in research, public health, and policy including positions with the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and, most recently, with the Addiction Policy Forum (APF). 

She holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).

###

 

BIOGRAPHY

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

Dr. Boyle brings over ten years of experience in research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), and, most recently, with the Addiction Policy Forum (APF).  

At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.  She oversaw many program areas including electronic heath records and health information exchange; privacy, confidentiality, and consent management practices; clinical quality measure development for behavioral health; and development and harmonization of behavioral health related data standards. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan, she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public, and she led development of research reports and other science communication materials. 

Most recently, as Chief Scientific Officer at APF, she communicated the science of addiction to diverse audiences and oversaw the development of the Addiction Resource Center and Helpline.   

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

Features

Education & Training

ASAM Hires Chief of Quality and Science

by ASAM Staff | Sep 05, 2018

The American Society of Addiction Medicine (ASAM) announced the hire of Maureen Boyle, PhD, as Chief Quality and Science Officer effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

She brings over ten years of experience in research, public health, and policy including positions with the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and, most recently, with the Addiction Policy Forum (APF). 

She holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).

###

 

BIOGRAPHY

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

Dr. Boyle brings over ten years of experience in research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), and, most recently, with the Addiction Policy Forum (APF).  

At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.  She oversaw many program areas including electronic heath records and health information exchange; privacy, confidentiality, and consent management practices; clinical quality measure development for behavioral health; and development and harmonization of behavioral health related data standards. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan, she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public, and she led development of research reports and other science communication materials. 

Most recently, as Chief Scientific Officer at APF, she communicated the science of addiction to diverse audiences and oversaw the development of the Addiction Resource Center and Helpline.   

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

Government Affairs

ASAM Hires Chief of Quality and Science

by ASAM Staff | Sep 05, 2018

The American Society of Addiction Medicine (ASAM) announced the hire of Maureen Boyle, PhD, as Chief Quality and Science Officer effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

She brings over ten years of experience in research, public health, and policy including positions with the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and, most recently, with the Addiction Policy Forum (APF). 

She holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).

###

 

BIOGRAPHY

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

Dr. Boyle brings over ten years of experience in research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), and, most recently, with the Addiction Policy Forum (APF).  

At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.  She oversaw many program areas including electronic heath records and health information exchange; privacy, confidentiality, and consent management practices; clinical quality measure development for behavioral health; and development and harmonization of behavioral health related data standards. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan, she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public, and she led development of research reports and other science communication materials. 

Most recently, as Chief Scientific Officer at APF, she communicated the science of addiction to diverse audiences and oversaw the development of the Addiction Resource Center and Helpline.   

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

OP-ED

ASAM Hires Chief of Quality and Science

by ASAM Staff | Sep 05, 2018

The American Society of Addiction Medicine (ASAM) announced the hire of Maureen Boyle, PhD, as Chief Quality and Science Officer effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

She brings over ten years of experience in research, public health, and policy including positions with the National Institute on Drug Abuse (NIDA), the Substance Abuse and Mental Health Services Administration (SAMHSA), and, most recently, with the Addiction Policy Forum (APF). 

She holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS).

###

 

BIOGRAPHY

Maureen Boyle, PhD, is the Chief Quality and Science Officer at the American Society of Addiction Medicine (ASAM) effective October 8th, 2018.  Dr. Boyle will provide strategic oversight and leadership of ASAM’s quality and science initiatives. These initiatives will enhance and expand ASAM’s efforts to promote improvements in the quality of addiction treatment across the nation and to increase the engagement of addiction medicine providers in research. 

Dr. Boyle brings over ten years of experience in research, public health, and policy including leadership positions with the Substance Abuse and Mental Health Services Administration (SAMHSA), National Institute on Drug Abuse (NIDA), and, most recently, with the Addiction Policy Forum (APF).  

At SAMHSA, as Team Lead for Health Information Technology (HIT) in the Center for Substance Abuse Treatment, Dr. Boyle coordinated the agency’s efforts to promote the use of technology to improve the delivery of substance use disorder treatment.  She oversaw many program areas including electronic heath records and health information exchange; privacy, confidentiality, and consent management practices; clinical quality measure development for behavioral health; and development and harmonization of behavioral health related data standards. 

Dr. Boyle also served as Chief of the Science Policy Branch at the NIDA. While directing and managing the Science Policy Branch, she led development of the institute’s strategic plan, she developed and presented analyses of the state of the science related to current policy issues for diverse audiences including congress, government agencies, and the public, and she led development of research reports and other science communication materials. 

Most recently, as Chief Scientific Officer at APF, she communicated the science of addiction to diverse audiences and oversaw the development of the Addiction Resource Center and Helpline.   

Dr. Boyle holds a PhD in Neuroscience from the Washington University School of Medicine, and she completed a postdoctoral fellowship at the Allen Institute for Brain Science and a Science and Technology Policy Fellowship through the American Association for the Advancement of Science (AAAS). 

Your ASAM

Photo of Alex Krawczyk-KeefeThe Importance of Donating: One Family’s Story

A donation to honor a son and help those facing the devastating disease of addiction.

ASAM Speaks on FDA Boxed Warnings

ASAM testified on the best approaches to communicating information about the fetal effects in product labeling for methadone and buprenorphine

Brain Stimulation as a Potential Treatment for Addiction

Brain stimulation has been in use for decades as a potential treatment for psychiatric disorders. However, its use in addiction is relatively new.

PCSS Graphic

Ask the PCSS Expert: Counseling Requirements in Addiction Treatment?

A physician wrote the PCSS mentor network seeking advice on what type of counseling (group/individual/ AA, NA/ therapist) are typically required as part of addiction treatment.